Star Equity Holdings, Inc. Announces 2022 Second Quarter Financial Results
Reported a 306% increase in Q2 2022 gross profit and a 19% increase in revenues Construction division reported a 54%...
Alex
Alex is a writer and digital content enthusiast who enjoys covering technology, current trends, useful tips, and topics that matter to everyday readers. With a focus on clear, informative, and easy-to-understand content, Alex aims to provide readers with practical insights and interesting perspectives across a wide range of subjects.
Hotel Market in Vietnam 2022-2026: A Flourishing Industry Set to Grow by $2.12 Billion – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Hotel Market in Vietnam 2022-2026" report has been added to ResearchAndMarkets.com's offering. The hotel market in Vietnam is...
Textile Fibers Markets in China: Demand to Grow by 7% Through 2031 – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Textile Fibers Markets in China" report has been added to ResearchAndMarkets.com's offering. China's demand for Textile Fibers has...
Polyurethane Markets in China: Demand to Grow at 4.5% through 2031 – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Polyurethane Markets in China" report has been added to ResearchAndMarkets.com's offering. China's demand for Polyurethane has grown at...
Home Improvement Markets in China: Demand to Grow at 8% Through 2031 – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Home Improvement Markets in China" report has been added to ResearchAndMarkets.com's offering. China's demand for Home Improvement has...
MUFG Bank, Ltd. announces Risk-Adjusted Capital Ratio Based on the Basel 3 Standards for the First Quarter Ended June 30, 2022
TOKYO--(BUSINESS WIRE)--MUFG hereby announces the risk-adjusted capital ratio based on the Basel 3 standards for the first quarter ended June...
InnoCare Announces Acceptance of Supplemental New Drug Application for Orelabrutinib in Relapsed or Refractory Marginal Zone Lymphoma in China
BEIJING--(BUSINESS WIRE)--InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company for the treatment of cancer and autoimmune diseases, announced today that...
Eurofins Strengthens Its Comprehensive Food Testing Offering in Japan Through the Acquisition of QSAI Analysis and Research Center Co.,Ltd.
LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific (EUFI.PA) (Paris:ERF), the global leader in food testing and a global scientific leader in bioanalytical...
Disclosure of data on Agaricus blazei mushroom, KA21’s immunity-enhancing mechanism, immunological enhancement effect confirmed by human clinical trials, and candida and other types of fungal infection, Toei Shinyaku
TOKYO--(BUSINESS WIRE)--On its website www.toeishinyaku.jp, Toei Shinyaku has disclosed data concerning the mechanism by which Agaricus blazei KA21 enhances immunity,...
Disclosure of data on effects of Agaricus blazei mushroom, KA21 strain for improvement of hair loss & gray hair in human clinical trials and promotion of hair growth in mice, Toei Shinyaku
TOKYO--(BUSINESS WIRE)--On its website www.toeishinyaku.jp, Toei Shinyaku has disclosed data from human clinical trials concerning the effects of Agaricus blazei...
Survey of degree of satisfaction with Agaricus blazei mushroom KA21 for promoting the health of senior dogs and cats among veterinarians and pet owners, Toei Shinyaku
Improvement of the appetite, coat & amount of fur, and amount of exercise among senior dogs and cats TOKYO--(BUSINESS WIRE)--A...
Toei Shinyaku Acquires Patent for Measurement Method of Beta-glucan, a Main Ingredient of Agaricus blazei mushroom
TOKYO--(BUSINESS WIRE)--Through its research on Agaricus blazei, KA21 strain, Toei Shinyaku has established a measurement method for beta-glucan, one of...
Announcement of Agaricus blazei mushroom, KA21 strain’s Ability to Improve QOL of Athletes at Annual Meeting, Toei Shinyaku
Athlete performance, overall condition, quality of sleep, sense of fatigue, mental condition, concentration ability, muscle condition, stamina, and resilience. TOKYO--(BUSINESS...
ENHERTU® Approved in the U.S. as the First HER2 Directed Therapy for Patients with Previously Treated HER2 Mutant Metastatic Non-Small Cell Lung Cancer
Based on DESTINY-Lung02 results which showed Daiichi Sankyo and AstraZeneca’s ENHERTU reported a confirmed objective response rate of 57.7% in...
Study into the Satisfaction Level of Veterinarians Regarding the Effects of Agaricus blazei mushroom, KA21 supplement on Dogs / Cats Malassezia and Dermatophytosis, Toei Shinyaku
TOKYO--(BUSINESS WIRE)--Toei Shinyaku conducted a survey to determine the effectiveness and veterinarian satisfaction level of Agaricus blazei KA21 supplement on...
